Polymorphisms Falling Within Putative miRNA Target Sites in the 3′UTR Region of SIRT2 and DRD2 Genes Are Correlated With Human Longevity

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 5, 2016, Pages 586-592

  Crocco, Paolina ^a   Montesanto, Alberto ^a   Passarino, Giuseppe ^a   Rose, Giuseppina ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

DRD2; Longevity; miRNA; SIRT2; SNP

Indexed keywords

3' UNTRANSLATED REGION; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, HUMAN; MICRORNA; SIRT2 PROTEIN, HUMAN; SIRTUIN 2;

3' UNTRANSLATED REGION; AGED; CASE CONTROL STUDY; FEMALE; GENETICS; GENOTYPE; HUMAN; LONGEVITY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; VERY ELDERLY;

3' UNTRANSLATED REGIONS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; LONGEVITY; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; SIRTUIN 2;

EID: 84965101983     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv058     Document Type: Article

References (62)

1. Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3-22. doi:10.1007/978-1-60327-411-1-1
2. Pennisi E. The biology of genomes. Disease risk links to gene regulation. Science. 2011;332:1031. doi:10.1126/science.332.6033.1031
3. Montesanto A, Dato S, Bellizzi D, Rose G, Passarino G. Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity. Immun Ageing. 2012;9:6. doi:10.1186/1742-4933-9-6
4. Glass D, Vinuela A, Davies MN, et al. Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol. 2013;14:R75. doi:10.1186/gb-2013-14-7-r75
5. Liu FJ, Wen T, Liu L. MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev. 2012;11:41-50. doi:10.1016/j.arr.2011.06.001
6. Grillari J, Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage. Exp Gerontol. 2010;45:302-311. doi:10.1016/j.exger.2010.01.007
7. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835-840. doi:10.1038/nature09267
8. Bushati N, Cohen SM. microRNA functions. Annu Review Cell Dev Biol. 2007;23:175-205. doi:10.1146/annurev.cellbio.23.090506.123406
9. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220:126-139. doi:10.1002/path.2638
10. Smith-Vikos T, Slack FJ. MicroRNAs and their roles in aging. J Cell Sci. 2012;125:7-17. doi:10.1242/jcs.099200
11. Badi I, Burba I, Ruggeri C, et al. MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors. J Gerontol A Biol Sci Med Sci. 2014; epub ahead of print. doi:10.1093/gerona/glu180
12. Ibáñez-Ventoso C, Yang M, Guo S, Robins H, Padgett RW, Driscoll M. Modulated microRNA expression during adult lifespan in Caenorhabditis elegans. Aging Cell. 2006;5:235-246. doi:10.1111/j.1474-9726.2006.00210.x
13. Maes OC, An J, Sarojini H, Wang E. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev. 2008;129:534-541. doi:10.1016/j.mad.2008.05.004
14. Li N, Bates DJ, An J, Terry DA, Wang E. Up-regulation of key microRNAs, and inverse down-regulation of their predicted oxidative phosphorylation target genes, during aging in mouse brain. Neurobiol Aging. 2011;32:944-955. doi:10.1016/j.neurobiolaging.2009.04.020
15. Liu N, Landreh M, Cao K, et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature. 2012;482:519-523. doi:10.1038/nature10810
16. Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, Evans MK. microRNA expression patterns reveal differential expression of target genes with age. PLoS One. 2010;5:e10724. doi:10.1371/journal.pone.0010724
17. Olivieri F, Spazzafumo L, Santini G, et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev. 2012;133:675-685. doi:10.1016/j.mad.2012.09.004
18. Zhang H, Yang H, Zhang C, et al. Investigation of microRNA expression in human serum during the aging process. J Gerontol A Biol Sci Med Sci. 2015;70:102-109. doi:10.1093/gerona/glu145
19. Lu J, Clark AG. Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012;22:1243-1254. doi:10.1101/gr.132514.111
20. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008;29:1306-1311. doi:10.1093/carcin/bgn116
21. Haas U, Sczakiel G, Laufer SD. MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3′-UTR via altered RNA structure. RNA Biol. 2012;9:924-937. doi:10.4161/rna.20497
22. Cipollini M, Landi S, Gemignani F. MicroRNA binding site polymorphisms as biomarkers in cancer management and research. Pharmgenomics Pers Med. 2014;7:173-191. doi:10.2147/PGPM.S61693
23. Mallick B, Ghosh Z. A complex crosstalk between polymorphic microRNA target sites and AD prognosis. RNA Biol. 2011;8:665-673. doi:10.4161/rna.8.4.15584
24. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet. 2007;81:405-413. doi:10.1086/519979
25. Martin MM, Buckenberger JA, Jiang J, et al. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 2007;282:24262-24269. doi:10.1074/jbc.M701050200
26. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38:209-213. doi:10.1038/ng1706
27. Liu C, Zhang F, Li T, et al. MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics. 2012;13:661. doi:10.1186/1471-2164-13-661
28. Bruno AE, Li L, Kalabus JL, Pan Y, Yu A, Hu Z. miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3′UTRs of human genes. BMC Genomics. 2012;13:44. doi:10.1186/1471-2164-13-44
29. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res. 2010;38:D640-D651. doi:10.1093/nar/gkp926
30. Bhattacharya A, Ziebarth JD, Cui Y. PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res. 2014;42:D86-D91. doi:10.1093/nar/gkt1028
31. Gong J, Tong Y, Zhang HM, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012;33:254-263. doi:10.1002/humu.21641
32. Thomas LF, Saito T, Saetrom P. Inferring causative variants in microRNA target sites. Nucleic Acids Res. 2011;39:e109. doi:10.1093/nar/gkr414
33. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36:D149-D153. doi:10.1093/nar/gkm995
34. Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within microRNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis. 2008;29:579-584. doi:10.1093/carcin/bgm304
35. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39:D152-D157. doi:10.1093/nar/gkq1027
36. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575. doi:10.1086/519795
37. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007;404:1-13. doi:10.1042/BJ20070140
38. Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci. 2010;35:669-675. doi:10.1016/j.tibs.2010.07.003
39. Crane FL, Navas P, Low H, Sun IL, de Cabo R. Sirtuin activation: a role for plasma membrane in the cell growth puzzle. J Gerontol A Biol Sci Med Sci. 2013;68:368-370. doi:10.1093/gerona/gls184
40. Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006;126:257-268. doi:10.1016/j.cell.2006.07.002
41. Hall JA, Dominy JE, Lee Y, Puigserver P. The sirtuin family's role in aging and age-associated pathologies. J Clin Invest. 2013;123:973-979. doi:10.1172/JCI64094
42. Lamming DW, Latorre-Esteves M, Medvedik O, et al. HST2 mediates SIR2-independent life-span extension by calorie restriction. Science. 2005;309:1861-1864. doi:10.1126/science.1113611
43. North BJ, Rosenberg MA, Jeganathan KB, et al. SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J. 2014;33:1438-1453. doi:10.15252/embj.201386907
44. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell. 2003;11:437-444. doi:10.1016/S1097-2765(03)00038-8
45. Vaquero A, Scher MB, Lee DH, et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 2006;20:1256-1261. doi:10.1101/gad.1412706
46. Inoue T, Hiratsuka M, Osaki M, Oshimura M. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle. 2007;6:1011-1018. doi:10.4161/cc.6.9.4219
47. de Oliveira RM, Sarkander J, Kazantsev AG, Outeiro TF. SIRT2 as a Therapeutic Target for Age-Related Disorders. Front Pharmacol. 2012;3:82. doi:10.3389/fphar.2012.00082
48. Hiratsuka M, Inoue T, Toda T, et al. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun. 2003;309:558-566. doi:10.1016/j.bbrc.2003.08.029
49. Li Z, Xie QR, Chen Z, Lu S, Xia W. Regulation of SIRT2 levels for human non-small cell lung cancer therapy. Lung Cancer. 2013;82:9-15. doi:10.1016/j.lungcan.2013.05.013
50. Kim HS, Vassilopoulos A, Wang RH, et al. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell. 2011;20:487-499. doi:10.1016/j.ccr.2011.09.004
51. Hulf T, Sibbritt T, Wiklund ED, et al. Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription. BMC Genomics. 2011;12:54. doi:10.1186/1471-2164-12-54
52. Gao W, Gu Y, Li Z, et al. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Oncogene. 2014; epub ahead of print. doi:10.1038/onc.2014.101
53. Hoss AG, Kartha VK, Dong X, et al. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis. PLoS Genet. 2014;10:e1004188. doi:10.1371/journal.pgen.1004188
54. Sondermeijer BM, Bakker A, Halliani A, et al. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340∗ and miRNA624∗. PloS One. 2011;6:e25946. doi:10.1371/journal.pone.0025946
55. Kim JY, Park YK, Lee KP, et al. Genome-wide profiling of the microRNA-mRNA regulatory network in skeletal muscle with aging. Aging. 2014;6:524-544.
56. Usiello A, Baik JH, Rouge-Pont F, et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 2000;408:199-203. doi:10.1038/35041572
57. Kaasinen V, Vilkman H, Hietala J, et al. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiology Aging. 2000;21:683-688. doi:10.1016/S0197-4580(00)00149-4
58. Backman L, Nyberg L, Lindenberger U, Li SC, Farde L. The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neuroscience Biobehav Rev. 2006;30:791-807. doi:10.1016/j.neubiorev.2006.06.005
59. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2003;116B:103-125. doi:10.1002/ajmg.b.10005
60. Shao W, Zhang SZ, Tang M, et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature. 2013;494:90-94. doi:10.1038/nature11748
61. Faghihi MA, Zhang M, Huang J, et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol. 2010;11:R56. doi:10.1186/gb-2010-11-5-r56
62. Shi S, Leites C, He D, et al. MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. J Biol Chem. 2014;289:13434-13444. doi:10.1074/jbc.M113.535203